Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease

Full text
Author(s):
Bueno, Valquiria [1] ; Sant'Anna, Osvaldo Augusto [2] ; Lord, Janet M. [3]
Total Authors: 3
Affiliation:
[1] UNIFESP Fed Univ Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo - Brazil
[2] Butantan Inst, Lab Immunochem, Sao Paulo - Brazil
[3] Univ Birmingham, MRC ARUK Ctr Musculoskeletal Ageing Res, Sch Immun & Infect, Birmingham, W Midlands - England
Total Affiliations: 3
Document type: Journal article
Source: AGE; v. 36, n. 6 DEC 2014.
Web of Science Citations: 30
Abstract

Infections, cancer and autoimmune diseases occur more frequently in the elderly, and although many factors contribute to this, the age-related remodelling of the immune system, termed immunosenescence, plays a major role. Over the last two decades, studies have evaluated the effect of ageing on both the adaptive and innate arms of the immune system and demonstrated compromised function in several cells including lymphocytes (naive, effector and memory), regulatory T and B cells, monocytes, neutrophils and NK cells. In addition, a well-documented feature of ageing is the increase in systemic inflammatory status (inflammageing), with raised serum levels of IL6, TNF alpha and CRP as well as reduced IL10. Recently, myeloid-derived suppressor cells have been the focus of many reports as these cells show immunosuppressive properties and are present in higher frequency during infections, cancer and autoimmunity. Importantly, there have been publications showing increased numbers of myeloid-derived suppressor cells in aged mice and humans. In this review, we discuss the current literature on myeloid-derived suppressor cells, their possible role in altered immune function in the elderly, and whether it may be possible to manipulate these cells to alleviate age-related immune dysfunction. (AU)

FAPESP's process: 13/07467-1 - CeTICS - Center of Toxins, Immune-Response and Cell Signaling
Grantee:Hugo Aguirre Armelin
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC
FAPESP's process: 12/51747-6 - Immune evaluation of ageing individuals and possible applications in vaccine
Grantee:Valquiria Bueno
Support Opportunities: Regular Research Grants